DRUG · Mapped RxNorm record
Spironolactone
Normalized identity: spironolactoneView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD Trial
NCT02285920
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedSafety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD Trial
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
End-Stage Renal Diseaseunresolved
Interventions
SpironolactoneDRUG · verified · RxNorm: spironolactone
Sponsors & collaborators
University of Pennsylvanialead sponsor
Brigham and Women's Hospitalcollaborator
George Washington Universitycollaborator
Vanderbilt Universitycollaborator
University of Washingtoncollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02285920 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.